4) Then there are the potential problems with the study. (Hat tip to @MicrobiomDigest). They somehow left out 4 patients who did worse. #COVID19 https://t.co/pnWk7owaC2 https://t.co/NVcHS1Gc1L— Eric Feigl-Ding (@DrEricDing) March 21, 2020
4) Then there are the potential problems with the study. (Hat tip to @MicrobiomDigest). They somehow left out 4 patients who did worse. #COVID19 https://t.co/pnWk7owaC2 https://t.co/NVcHS1Gc1L